QU Quartr MEDX: Adjusted EBITDA margin rose to 20.3% as Healthcare growth offset Consumer & Industrial declines
Quartr
- Sources
- Quartr
- Markets
- Stocks
- Active symbols
- SIX:MEDX
- Language
- English
Revenue declined 1.6% organically, with Healthcare growth offset by Consumer & Industrial weakness. Adjusted EBITDA margin improved to 20.3%, and free cash flow rose 4.6%. Full-year guidance and midterm targets remain unchanged.Original document: medmix AG [MEDX] Earnings Release — Jul. 23 2026This…
Revenue declined 1.6% organically, with Healthcare growth offset by Consumer & Industrial weakness. Adjusted EBITDA margin improved to 20.3%, and free cash flow rose 4.6%. Full-year guidance and midterm targets remain unchanged.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
